| Person Name | Explanation |
|---|---|
| Sarah Jane Moore | None of the trustees receive any compensation. |
| Christine Thornburg | None of the trustees receive any compensation. |
| John Moore | None of the trustees receive any compensation. |
| Mary Ellen Moore | None of the trustees receive any compensation. |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| KKR | 2014-05 | Purchase | 2020-01 | 88,168 | 69,889 | 0 | 88,168 | 0 | ||
| ALS ETF TR ALERIAN MLP | 2020-01 | Purchase | 2020-03 | 15,123 | 39,050 | 0 | 15,123 | 0 | ||
| CYRUSONE INC COM | 2020-01 | 1753-01 | 0 | 0 | 0 | 0 | 0 | |||
| LADDER CAP CORP | 2020-10 | 1753-01 | 0 | 0 | 0 | 0 | 0 | |||
| OMEGA HEALTHCARE | 2020-12 | 1753-01 | 0 | 0 | 0 | 0 | 0 | |||
| STORE CAP CORP | 2020-10 | 1753-01 | 0 | 0 | 0 | 0 | 0 | |||
| Change Healthcare | 2020-01 | Purchase | 2020-03 | 8 | 11 | 0 | 8 | 0 | ||
| Occidental Pete | 2020-08 | Purchase | 2020-08 | 3 | 3 | 0 | 3 | 0 | ||
| LARIMAR | 2014-06 | Purchase | 2020-05 | 4 | 64 | 0 | 4 | 0 | ||
| XBIOTECH | 2015-04 | Purchase | 2020-02 | 421 | 1,254 | 0 | 421 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| UBS GROUP | 180,214 | 180,214 |
| OBSEVA USA | 208 | 208 |
| ATENTO SA | 816 | 816 |
| YANDEX | 6,958 | 6,958 |
| CHANGE HEALTHCARE | 5,091 | 5,091 |
| DIGIRAD | 3,590 | 3,590 |
| ELANCO ANIMAL HEALTH | 429 | 429 |
| EVOFEM BIOSCIENCES | 39 | 39 |
| EXTRACTION OIL & GAS | 3 | 3 |
| FIRST HAWAIIAN | 2,358 | 2,358 |
| KALVISTA PHARMA | 399 | 399 |
| KINDRED BIO | 431 | 431 |
| LARIMAR THERAPEUTICS | 171 | 171 |
| LAUREATE ED | 1,456 | 1,456 |
| MPLX LP | 736 | 736 |
| MCKESSON | 23,653 | 23,653 |
| NGL ENERGY PARTNERS | 9,360 | 9,360 |
| NGL ENERGY PARTNERS | 0 | 0 |
| OCCIDENTAL PETE | 9,088 | 9,088 |
| ROCKET PHARMA | 1,371 | 1,371 |
| SOUTHCROSS ENERGY | 0 | 0 |
| TEVA PHARMA | 6,359 | 6,359 |
| X BIOTECH | 2,097 | 2,097 |
| ZAFGEN | 0 | 0 |
| ZTO EXPRESS | 2,916 | 2,916 |
| CYRUSONE | 7,315 | 7,315 |
| LADDER CAP | 1,095 | 1,095 |
| OCCIDENTAL PETE | 443 | 443 |
| OMEGA HEALTHCARE | 3,269 | 3,269 |
| PARAMOUNT GRP | 904 | 904 |
| STORE CAPITAL | 3,398 | 3,398 |
| KKR | 0 | 0 |
| Category/ Item | Cost/Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|---|---|---|---|
| Land | 0 | 0 | ||
| Buildings | 0 | 0 | ||
| Leasehold improvements | 0 | 0 | ||
| Equipment | 0 | 0 |
| Description | Amount |
|---|---|
| CHANGE IN INVESTMENT VALUE | 39,524 |
| Description | Amount |
|---|---|
| CAPITAL GAIN DISTRIBUTIONS | 138 |
| NONDIVIDEND DISTRIBUTIONS | 3,351 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Margin Loan Balance | 93,423 | 86,646 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TRANSACTION COSTS, FEES, CHARGES PAID TO FIDELITY | 5 | 5 | 0 | 5 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 2,019 | 2,019 | 0 | 2,019 |
| EXCISE TAX PAID IRS | 70 | 70 | 0 | 70 |